Clinical trial

Single Ascending Doses of GGF2 in Patients With Left Ventricular Dysfunction and Symptomatic Heart Failure

NCT01258387

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-12-01

PhasePHASE1

Study timeline

Study start (unknown)2010-12-01Date precision: month

Registry last updated2014-07-01

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Heart Failureunresolved

Interventions

Glial growth factor 2/ Neuregulin 1β3DRUG

PlaceboOTHER

Sponsors & collaborators

Acorda Therapeuticslead sponsor

Mapped research locations

AtlantaGeorgia, United States1 NashvilleTennessee, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01258387 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.